Cancer Research and Treatment10.4143/crt.2016.3262017493807-815CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin ChemotherapyDae-Won Lee, Seock-Ah Im, Yu Jung Kim, Yaewon Yang, Jiyoung Rhee, Im Il Na, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, In Sil Choi, Do-Youn Oh, Jee Hyun Kim, Tae-You Kim, Yung-Jue Bang,,
Annals of Oncology10.1093/annonc/mdy151.105201829v29Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin chemotherapy: retrospective analysis of 142 patientsH. Engin,,
Cancer Treatment and Research Communications10.1016/j.ctarc.2021.100335202127100335First-line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC-02 Trial: “And Yet It Moves!”Alessandro Rizzo, Giovanni Brandi,
Annals of Oncology10.1093/annonc/mdt203.120201324iv70Gemcitabine Plus Cisplatin Versus Gemcitabine Chemotherapy for Advanced Biliary Tract CancerJinmyung Park, Jikon Ryu,,
Chemotherapy10.1159/0003545392013593232-238Gemcitabine plus Cisplatin versus Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Cohort StudySang Myung Woo, Woo Jin Lee, Ji Hun Kim, Dong Hwan Kim, Sung-Sik Han, Sang-Jae Park, Tae Hyun Kim, Ju Hee Lee, Young Hwan Koh, Eun Kyung Hong,
British Journal of Cancer10.1038/bjc.2016.44620171165561-567Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patientsBum Jun Kim, Changhoon Yoo, Kyu-pyo Kim, Jaewon Hyung, Seong Joon Park, Baek-Yeol Ryoo, Heung-Moon Chang,,
Journal of Gastroenterology10.1007/s00535-018-1518-32018543281-290Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapyYuko Suzuki, Motoyasu Kan, Gen Kimura, Kumiko Umemoto, Kazuo Watanabe, Mitsuhito Sasaki, Hideaki Takahashi, Yusuke Hashimoto, Hiroshi Imaoka, Izumi Ohno, Shuichi Mitsunaga, Masafumi Ikeda,,
Oncology Research and Treatment10.1159/0005070932020439460-469Comparison between Fluoropyrimidine-Cisplatin and Gemcitabine-Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Meta-AnalysisTing Zheng, Jianjiang Jin, Li Zhou, Yuefeng Zhang,
Cancer10.1002/cncr.115742003984745-752Advanced seminoma?Treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent diseaseDany Gholam, Karim Fizazi, Marie-Jose Terrier-Lacombe, Pascale Jan, Stephane Culine, Christine Theodore,
Medical Oncology10.1007/s12032-016-0817-x2016339CA19-9-related tumor kinetics after first-line chemotherapy of patients with advanced pancreatic cancer: a monoinstitutional experienceGiuseppe Colloca, Antonella Venturino, Domenico Guarneri,,